| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |